|
|
|
|||
|
(State or other jurisdiction of incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
|
|
|
|
|
(Address of principal executive offices)
|
(Zip Code)
|
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
Soliciting material pursuant to Rule l4a-12 under the Exchange Act (17 CFR 240.l4a-12)
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
|
|
|
|
| Item 2.02. |
Results of Operations and Financial Condition
|
| Item 9.01. |
Financial Statements and Exhibits.
|
|
Exhibit No.
|
Description
|
|
| 99.1 |
Press Release, dated June 14, 2021
|
|
|
104
|
Cover Page Interactive Data File (embedded within the Inline XBRL document).
|
|
MOTORCAR PARTS OF AMERICA, INC.
|
|
|
Date: June 14, 2021
|
/s/ David Lee
|
|
David Lee
|
|
|
Chief Financial Officer
|
![]() |
NEWS RELEASE
|
|
Three Months Ended March 31,
|
Year Ended March 31,
|
|||||||||||||||
|
2021
|
2020
|
2021
|
2020
|
|||||||||||||
|
(Unaudited)
|
||||||||||||||||
|
Net sales
|
$
|
168,128,000
|
$
|
150,735,000
|
$
|
540,782,000
|
$
|
535,831,000
|
||||||||
|
Cost of goods sold
|
136,021,000
|
114,152,000
|
431,321,000
|
417,431,000
|
||||||||||||
|
Gross profit
|
32,107,000
|
36,583,000
|
109,461,000
|
118,400,000
|
||||||||||||
|
Operating expenses:
|
||||||||||||||||
|
General and administrative
|
15,637,000
|
13,814,000
|
53,847,000
|
53,224,000
|
||||||||||||
|
Sales and marketing
|
4,800,000
|
5,047,000
|
18,024,000
|
21,037,000
|
||||||||||||
|
Research and development
|
2,549,000
|
2,506,000
|
8,563,000
|
9,200,000
|
||||||||||||
|
Foreign exchange impact of lease liabilities and forward contracts
|
3,651,000
|
20,708,000
|
(17,606,000
|
)
|
18,201,000
|
|||||||||||
|
Total operating expenses
|
26,637,000
|
42,075,000
|
62,828,000
|
101,662,000
|
||||||||||||
|
Operating income (loss)
|
5,470,000
|
(5,492,000
|
)
|
46,633,000
|
16,738,000
|
|||||||||||
|
Interest expense, net
|
3,696,000
|
5,464,000
|
15,770,000
|
25,039,000
|
||||||||||||
|
Income (loss) before income tax expense (benefit)
|
1,774,000
|
(10,956,000
|
)
|
30,863,000
|
(8,301,000
|
)
|
||||||||||
|
Income tax expense (benefit)
|
939,000
|
(2,763,000
|
)
|
9,387,000
|
(1,011,000
|
)
|
||||||||||
|
Net income (loss)
|
$
|
835,000
|
$
|
(8,193,000
|
)
|
$
|
21,476,000
|
$
|
(7,290,000
|
)
|
||||||
|
Basic net income (loss) per share
|
$
|
0.04
|
$
|
(0.43
|
)
|
$
|
1.13
|
$
|
(0.39
|
)
|
||||||
|
Diluted net income (loss) per share
|
$
|
0.04
|
$
|
(0.43
|
)
|
$
|
1.11
|
$
|
(0.39
|
)
|
||||||
|
Weighted average number of shares outstanding:
|
||||||||||||||||
|
Basic
|
19,044,407
|
18,967,865
|
19,023,145
|
18,913,788
|
||||||||||||
|
Diluted
|
19,585,638
|
18,967,865
|
19,387,555
|
18,913,788
|
||||||||||||
|
March 31, 2021
|
March 31, 2020
|
|||||||
|
ASSETS
|
||||||||
|
Current assets:
|
||||||||
|
Cash and cash equivalents
|
$
|
15,523,000
|
$
|
49,616,000
|
||||
|
Short-term investments
|
1,652,000
|
850,000
|
||||||
|
Accounts receivable — net
|
63,122,000
|
91,748,000
|
||||||
|
Inventory — net
|
288,361,000
|
225,659,000
|
||||||
|
Inventory unreturned
|
14,552,000
|
9,021,000
|
||||||
|
Contract assets
|
26,940,000
|
20,332,000
|
||||||
|
Income tax receivable
|
405,000
|
3,282,000
|
||||||
|
Prepaid expenses and other current assets
|
12,301,000
|
8,608,000
|
||||||
|
Total current assets
|
422,856,000
|
409,116,000
|
||||||
|
Plant and equipment — net
|
53,854,000
|
44,957,000
|
||||||
|
Operating lease assets
|
71,513,000
|
53,029,000
|
||||||
|
Deferred income taxes
|
19,381,000
|
18,950,000
|
||||||
|
Long-term contract assets
|
270,213,000
|
239,540,000
|
||||||
|
Goodwill
|
3,205,000
|
3,205,000
|
||||||
|
Intangible assets — net
|
5,329,000
|
6,393,000
|
||||||
|
Other assets
|
1,531,000
|
1,839,000
|
||||||
|
TOTAL ASSETS
|
$
|
847,882,000
|
$
|
777,029,000
|
||||
|
LIABILITIES AND SHAREHOLDERS’ EQUITY
|
||||||||
|
Current liabilities:
|
||||||||
|
Accounts payable
|
$
|
129,331,000
|
$
|
78,664,000
|
||||
|
Accrued liabilities
|
23,404,000
|
16,419,000
|
||||||
|
Customer finished goods returns accrual
|
31,524,000
|
25,326,000
|
||||||
|
Contract liabilities
|
41,072,000
|
27,911,000
|
||||||
|
Revolving loan
|
84,000,000
|
152,000,000
|
||||||
|
Other current liabilities
|
6,683,000
|
9,390,000
|
||||||
|
Operating lease liabilities
|
6,439,000
|
5,104,000
|
||||||
|
Current portion of term loan
|
3,678,000
|
3,678,000
|
||||||
|
Total current liabilities
|
326,131,000
|
318,492,000
|
||||||
|
Term loan, less current portion
|
16,786,000
|
20,462,000
|
||||||
|
Contract liabilities, less current portion
|
125,223,000
|
92,101,000
|
||||||
|
Deferred income taxes
|
73,000
|
79,000
|
||||||
|
Operating lease liabilities, less current portion
|
70,551,000
|
61,425,000
|
||||||
|
Other liabilities
|
7,973,000
|
8,950,000
|
||||||
|
Total liabilities
|
546,737,000
|
501,509,000
|
||||||
|
Commitments and contingencies
|
||||||||
|
Shareholders’ equity:
|
||||||||
|
Preferred stock; par value $.01 per share, 5,000,000 shares authorized; none issued
|
-
|
-
|
||||||
|
Series A junior participating preferred stock; par value $.01 per share, 20,000 shares authorized; none issued
|
-
|
-
|
||||||
|
Common stock; par value $.01 per share, 50,000,000 shares authorized; 19,045,386 and 18,969,380 shares issued and outstanding at March 31, 2021 and 2020, respectively
|
190,000
|
190,000
|
||||||
|
Additional paid-in capital
|
223,058,000
|
218,581,000
|
||||||
|
Retained earnings
|
85,593,000
|
64,117,000
|
||||||
|
Accumulated other comprehensive loss
|
(7,696,000
|
)
|
(7,368,000
|
)
|
||||
|
Total shareholders’ equity
|
301,145,000
|
275,520,000
|
||||||
|
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY
|
$
|
847,882,000
|
$
|
777,029,000
|
||||
| Items Impacting Net Income (Loss) for the Three Months Ended March 31, 2021 and 2020 | Exhibit 1 |
|
Three Months Ended March 31,
|
||||||||||||||||
|
2021
|
2020
|
|||||||||||||||
| $ |
Per Share
|
|
$ |
Per Share
|
||||||||||||
|
GAAP net income (loss)
|
$
|
835,000
|
$
|
0.04
|
$
|
(8,193,000
|
)
|
$
|
(0.43
|
)
|
||||||
|
Items impacting net income (loss)
|
||||||||||||||||
|
Customer allowances related to new business
|
$
|
101,000
|
$
|
0.01
|
$
|
(54,000
|
)
|
$
|
(0.00
|
)
|
||||||
|
Core premium amortization impacting net sales
|
2,321,000
|
0.12
|
958,000
|
0.05
|
||||||||||||
|
Impact of tariffs
|
306,000
|
0.02
|
-
|
-
|
||||||||||||
|
New product line start-up costs and transition expenses (a)
|
5,203,000
|
0.27
|
2,816,000
|
0.15
|
||||||||||||
|
Revaluation - cores on customers’ shelves
|
1,020,000
|
0.05
|
932,000
|
0.05
|
||||||||||||
|
Increased expenses related to COVID-19 (b)
|
2,825,000
|
0.14
|
-
|
-
|
||||||||||||
|
Earn-out accruals and severance
|
1,372,000
|
0.07
|
(553,000
|
)
|
(0.03
|
)
|
||||||||||
|
Share-based compensation expenses
|
1,488,000
|
0.08
|
1,029,000
|
0.05
|
||||||||||||
|
Foreign exchange impact of lease liabilities and forward contracts
|
3,651,000
|
0.19
|
20,708,000
|
1.09
|
||||||||||||
|
Tax effect (c)
|
(4,572,000
|
)
|
(0.23
|
)
|
(6,459,000
|
)
|
(0.34
|
)
|
||||||||
|
Total items impacting net income (loss)
|
$
|
13,715,000
|
$
|
0.70
|
$
|
19,377,000
|
$
|
1.02
|
||||||||
| Items Impacting Net Income (Loss) for the Years Ended March 31, 2021 and 2020 |
Exhibit 2
|
|
Year Ended March 31,
|
||||||||||||||||
|
2021
|
2020
|
|||||||||||||||
|
|
$ |
Per Share
|
$ |
Per Share
|
||||||||||||
|
GAAP net income (loss)
|
$
|
21,476,000
|
$
|
1.11
|
$
|
(7,290,000
|
)
|
$
|
(0.39
|
)
|
||||||
|
Items impacting net income (loss)
|
||||||||||||||||
|
Customer allowances, return accruals and changeover costs (a) related to new business, net of costs
|
$
|
408,000
|
$
|
0.02
|
$
|
1,177,000
|
$
|
0.06
|
||||||||
|
Core premium amortization impacting net sales
|
6,590,000
|
0.34
|
4,501,000
|
0.24
|
||||||||||||
|
Impact of tariffs
|
(3,229,000
|
)
|
(0.17
|
)
|
1,067,000
|
0.06
|
||||||||||
|
Cost in connection with a cancelled contract
|
-
|
-
|
133,000
|
0.01
|
||||||||||||
|
New product line start-up costs and transition expenses (b)
|
17,767,000
|
0.92
|
10,281,000
|
0.54
|
||||||||||||
|
Revaluation - cores on customers’ shelves, and gain due to realignment of inventory at two customer distribution centers
|
209,000
|
0.01
|
10,799,000
|
0.57
|
||||||||||||
|
Increased expenses related to COVID-19 (c)
|
9,101,000
|
0.47
|
-
|
-
|
||||||||||||
|
Acquisition costs, earn-out accruals, severance and restatement-related fees
|
1,391,000
|
0.07
|
(261,000
|
)
|
(0.01
|
)
|
||||||||||
|
Share-based compensation expenses
|
5,247,000
|
0.27
|
4,141,000
|
0.22
|
||||||||||||
|
Foreign exchange impact of lease liabilities and forward contracts
|
(17,606,000
|
)
|
(0.91
|
)
|
18,201,000
|
0.96
|
||||||||||
|
Tax effect (d)
|
(4,970,000
|
)
|
(0.26
|
)
|
(12,510,000
|
)
|
(0.66
|
)
|
||||||||
|
Total items impacting net income (loss)
|
$
|
14,908,000
|
$
|
0.77
|
$
|
37,529,000
|
$
|
1.98
|
||||||||
| Items Impacting Gross Profit for the Three Months Ended March 31, 2021 and 2020 |
Exhibit 3
|
|
Three Months Ended March 31,
|
||||||||||||||||
|
2021
|
2020
|
|||||||||||||||
|
|
$
|
Gross Margin
|
|
$ |
Gross Margin
|
|||||||||||
|
GAAP gross profit
|
$
|
32,107,000
|
19.1
|
%
|
$
|
36,583,000
|
24.3
|
%
|
||||||||
|
Items impacting gross profit
|
||||||||||||||||
|
Customer allowances related to new business
|
$
|
101,000
|
0.1
|
%
|
$
|
(54,000
|
)
|
0.0
|
%
|
|||||||
|
Core premium amortization impacting net sales
|
2,321,000
|
1.4
|
%
|
958,000
|
0.6
|
%
|
||||||||||
|
Impact of tariffs
|
306,000
|
0.2
|
%
|
-
|
-
|
|||||||||||
|
New product line start-up costs and transition expenses
|
4,781,000
|
2.8
|
%
|
2,508,000
|
1.7
|
%
|
||||||||||
|
Revaluation - cores on customers’ shelves
|
1,020,000
|
0.6
|
%
|
932,000
|
0.6
|
%
|
||||||||||
|
Increased expenses related to COVID-19
|
2,305,000
|
1.4
|
%
|
-
|
-
|
|||||||||||
|
Total items impacting gross profit
|
$
|
10,834,000
|
6.4
|
%
|
$
|
4,344,000
|
2.9
|
%
|
||||||||
| Items Impacting Gross Profit for the Years Ended March 31, 2021 and 2020 |
Exhibit 4
|
|
Year Ended March 31,
|
||||||||||||||||
|
2021
|
2020
|
|||||||||||||||
| $ |
Gross Margin
|
|
$ |
Gross Margin
|
||||||||||||
|
GAAP gross profit
|
$
|
109,461,000
|
20.2
|
%
|
$
|
118,400,000
|
22.1
|
%
|
||||||||
|
Items impacting gross profit
|
||||||||||||||||
|
Customer allowances and return accruals related to new business, net of costs
|
$
|
408,000
|
0.1
|
%
|
$
|
1,065,000
|
0.2
|
%
|
||||||||
|
Core premium amortization impacting net sales
|
6,590,000
|
1.2
|
%
|
4,501,000
|
0.8
|
%
|
||||||||||
|
Impact of tariffs
|
(3,229,000
|
)
|
-0.6
|
%
|
1,067,000
|
0.2
|
%
|
|||||||||
|
Cost in connection with a cancelled contract
|
-
|
-
|
133,000
|
0.0
|
%
|
|||||||||||
|
New product line start-up costs and transition expenses
|
16,353,000
|
3.0
|
%
|
8,337,000
|
1.6
|
%
|
||||||||||
|
Revaluation - cores on customers’ shelves, and gain due to realignment of inventory at two customer distribution centers (a)
|
209,000
|
0.5
|
%
|
10,799,000
|
2.0
|
%
|
||||||||||
|
Increased expenses related to COVID-19
|
7,053,000
|
1.3
|
%
|
-
|
-
|
|||||||||||
|
Total items impacting gross profit
|
$
|
27,384,000
|
5.5
|
%
|
$
|
25,902,000
|
4.8
|
%
|
||||||||
| Items Impacting EBITDA for the Three Months and Years Ended March 31, 2021 and 2020 |
Exhibit 5
|
|
Three Months Ended March 31,
|
Year Ended March 31,
|
|||||||||||||||
|
2021
|
2020
|
2021
|
2020
|
|||||||||||||
|
GAAP net income (loss)
|
$
|
835,000
|
$
|
(8,193,000
|
)
|
$
|
21,476,000
|
$
|
(7,290,000
|
)
|
||||||
|
Interest expense, net
|
3,696,000
|
5,464,000
|
15,770,000
|
25,039,000
|
||||||||||||
|
Income tax expense (benefit)
|
939,000
|
(2,763,000
|
)
|
9,387,000
|
(1,011,000
|
)
|
||||||||||
|
Depreciation and amortization
|
3,054,000
|
2,542,000
|
11,144,000
|
9,561,000
|
||||||||||||
|
EBITDA
|
$
|
8,524,000
|
$
|
(2,950,000
|
)
|
$
|
57,777,000
|
$
|
26,299,000
|
|||||||
|
Items impacting EBITDA
|
||||||||||||||||
|
Customer allowances, return accruals and changeover costs related to new business, net of costs
|
$
|
101,000
|
$
|
(54,000
|
)
|
$
|
408,000
|
$
|
1,177,000
|
|||||||
|
Core premium amortization impacting net sales
|
2,321,000
|
958,000
|
6,590,000
|
4,501,000
|
||||||||||||
|
Impact of tariffs
|
306,000
|
-
|
(3,229,000
|
)
|
1,067,000
|
|||||||||||
|
Cost in connection with a cancelled contract
|
-
|
-
|
-
|
133,000
|
||||||||||||
|
New product line start-up costs and transition expenses (a)
|
4,969,000
|
2,752,000
|
17,204,000
|
9,998,000
|
||||||||||||
|
Revaluation - cores on customers’ shelves, and gain due to realignment of inventory at two customer distribution centers
|
1,020,000
|
932,000
|
209,000
|
10,799,000
|
||||||||||||
|
Increased expenses related to COVID-19
|
2,825,000
|
-
|
9,101,000
|
-
|
||||||||||||
|
Acquisition costs, earn-out accruals, severance and restatement-related fees
|
1,372,000
|
(553,000
|
)
|
1,391,000
|
(261,000
|
)
|
||||||||||
|
Share-based compensation expenses
|
1,488,000
|
1,029,000
|
5,247,000
|
4,141,000
|
||||||||||||
|
Foreign exchange impact of lease liabilities and forward contracts
|
3,651,000
|
20,708,000
|
(17,606,000
|
)
|
18,201,000
|
|||||||||||
|
Total items impacting EBITDA
|
$
|
18,053,000
|
$
|
25,772,000
|
$
|
19,315,000
|
$
|
49,756,000
|
||||||||